
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orchestrated Copper-Loaded Nanoreactor for Simultaneous Induction of Cuproptosis and Immunotherapeutic Intervention in Colorectal Cancer
Jiasheng Li, Shanshan Ma, Lin Qiu-hua, et al.
Materials Today Bio (2024) Vol. 29, pp. 101326-101326
Open Access | Times Cited: 1
Jiasheng Li, Shanshan Ma, Lin Qiu-hua, et al.
Materials Today Bio (2024) Vol. 29, pp. 101326-101326
Open Access | Times Cited: 1
Showing 1 citing articles:
NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy
Lushuang Xu, Qinyue Chen, Yangwei Qian, et al.
Chemical Engineering Journal (2025), pp. 161733-161733
Closed Access
Lushuang Xu, Qinyue Chen, Yangwei Qian, et al.
Chemical Engineering Journal (2025), pp. 161733-161733
Closed Access
Tumor-targeting Nanomaterials Based on Metal-organic Frameworks Mediate Tumor Immunotherapy by Promoting Cuproptosis and Pyroptosis in Hepatocellular Carcinoma Cells
Xiaoyuan Yi, Huaying Xie, Kunzhao Huang, et al.
Materials Today Bio (2025), pp. 101745-101745
Open Access
Xiaoyuan Yi, Huaying Xie, Kunzhao Huang, et al.
Materials Today Bio (2025), pp. 101745-101745
Open Access
An up‐To‐Date Review of Elesclomol and Its Nano‐Formulations in Cancer Therapy
Qi Wang, Feng Li, Amit K. Tiwari, et al.
Cancer Reports (2025) Vol. 8, Iss. 4
Open Access
Qi Wang, Feng Li, Amit K. Tiwari, et al.
Cancer Reports (2025) Vol. 8, Iss. 4
Open Access
An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restoring cetuximab chemosensitivity
Yurong Xiang, Qiang Liu, Kang Liu, et al.
Materials Today Bio (2025), pp. 101732-101732
Open Access
Yurong Xiang, Qiang Liu, Kang Liu, et al.
Materials Today Bio (2025), pp. 101732-101732
Open Access